Analysis
| Earnings estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 4 | 4 | 25 | 27 |
| Average estimate | 34.62 | 35.38 | 132.26 | 173.95 |
| Low estimate | 31.60 | 31.90 | 118.54 | 148.82 |
| High estimate | 36.90 | 36.90 | 144.49 | 197.40 |
| Last year EPS | 26.34 | 25.89 | 100.56 | 132.26 |
| Revenue estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 4 | 4 | 26 | 27 |
| Avg. estimate | 63.14B | 63.69B | 253.50B | 306.81B |
| Low estimate | 60.87B | 62.38B | 245.51B | 279.30B |
| High estimate | 64.93B | 65.34B | 266.42B | 393.78B |
| Last year sales | 55.89B | 55.27B | 217.94B | 253.50B |
| Sales growth | 0.13 | 0.15 | 0.16 | 0.21 |
| EPS trend |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 34.62 | 35.38 | 132.26 | 173.95 |
| 7 days ago | 32.08 | 31.47 | 132.28 | 173.97 |
| 30 days ago | 32.08 | 31.47 | 131.60 | 171.39 |
| 60 days ago | 32.79 | 30.29 | 131.76 | 171.68 |
| 90 days ago | 39.46 | 35.49 | 130.32 | 171.34 |
| EPS revisions |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 1 | 1 | 16 | 12 |
| Up last 30 days | 1 | 1 | 16 | 12 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 0 | 0 | 4 | 8 |